Overview

Gentian Violet Treatment for Hidradenitis Suppurativa

Status:
Not yet recruiting

Trial end date:
2022-04-01

Target enrollment:
0

Participant gender:
All

Summary

This is a survey study being conducted to describe how subjects with Hidradenitis suppurativa (HS) respond to treatment with gentian violet. The study will rely primarily on qualitative survey responses and quantitative changes in skin appearance.

Phase:

Phase 2

Accepts Healthy Volunteers?

Details

Lead Sponsor:

Wake Forest University Health Sciences

Treatments:

Gentian Violet

Criteria

Inclusion Criteria:

- Patients must have active HS, be willing to undergo one application of HS, and agree
to follow-up in one month.

Exclusion Criteria:

- Exclusion criteria include children, absent HS lesions at the time of clinic, and
cognitive/physical impairments that would make them unable to assess quality of life
factors of the survey.